Literature DB >> 25435676

Relationship among Ocular Diseases, Developmental Levels, and Clinical Characteristics of Children with Diplegic Cerebral Palsy.

Ahmet Boyaci1, Ali Akal2, Ahmet Tutoglu1, Hasan Kandemir3, Irfan Koca4, Ismail Boyraz5, Esra Celen1, Ufuk Ozkan2.   

Abstract

[Purpose] The aim of this study was to evaluate the relationships among vision problems, developmental levels, upper extremity functions, and qualities of life of children with cerebral palsy (CP). [Subjects] The study included 32 children, aged 4-15 years, diagnosed with diplegic type CP. [Methods] Hand function was evaluated using the Manual Ability Classification System (MACS) and the Bimanual Fine Motor Function (BFMF) scale, and the severity of CP was assessed using the Gross Motor Function Classification System (GMFCS). The developmental and mental capabilities of the children were evaluated using the Ankara Developmental Screening Inventory (ADSI) or the WISC-R test. An oculomotor examination was conducted for all patients.
[Results] Positive correlations were found between GMFCS and BFMF, GMFCS and MACS, and MACS and BFMF scores (r=0.636; r=0.553; r=0.718, respectively). Significant correlations were found between upper extremity function, the severity of CP, the quality of life, and the general developmental level. There was no significant correlation between ocular disorders and clinical characteristics.
[Conclusion] GMFCS, MACS, and BFMF may be useful for defining the functional status of children with CP, as they are easy, practical, and simple classification scales that conform to each other.

Entities:  

Keywords:  Cerebral palsy; Gross motor function; Ocular disorders

Year:  2014        PMID: 25435676      PMCID: PMC4242931          DOI: 10.1589/jpts.26.1679

Source DB:  PubMed          Journal:  J Phys Ther Sci        ISSN: 0915-5287


INTRODUCTION

Cerebral palsy (CP) is a chronic, non-progressive clinical disease characterised by movement and posture impairments in children which is associated with permanent brain damage occurring in the perinatal or natal period1). The patient may be affected by motor, tonus and posture disorders as well as a wide spectrum of problems associated with cerebral dysfunction such as learning difficulties, autonomic dysfunction, epilepsy, mental retardation, and sight and hearing problems2). The prevalence of CP in Turkey has been stated as 4.4 per 1,000 live births3). The most frequently seen type of CP in the Turkish population is diplegic CP, and in 71.6% of these cases there is a history of prematurity3). Spastic diplegia may be seen in both term and pre-term infants. In pre-term diplegic CP patients there is often a relationship with periventricular leukomalacia. Lower extremity involvement is more evident and patients have relatively better hand functions. According to the severity of the effect, advanced function loss in the upper extremity may be associated with the degree of spasticity, the presence of contracture, sensory loss or mental level4). Ophthalmological problems are seen in 50–90% of CP patients5,6,7). Within the CP types, it has been reported that ophthalmological problems occur more often in diplegic type spastic CP6,7,8). Refractive errors and strabismus are the most often seen ophthalmological problems in CP5,6,7). In a study evaluating the relationship between CP etiology and ocular and visual diseases, it was reported that particularly for patients with diplegic and triplegic CP with positive neuroradiological findings together with pre-term patients with low birth-weight, there is a need for an ophthalmological examination as early as possible9). In a study which evaluated the hand functions using the Manual Ability Classification System (MACS) and the Bimanual Fine Motor Function (BFMF) scale, and the severity of CP with the Gross Motor Function Classification System (GMFCS), it was reported that in the evaluation of the hand functions of children with CP, the MACS and BFMF scales are consistent with each other and with the GMFCS10). Ocular diseases which develop in CP patients and the developmental level can affect the functional level and quality of life of the patient. To the best of our knowledge, there is no study in the literature which has researched the relationship of ocular diseases or developmental level with upper extremity functions, daily living activities and quality of life of diplegic CP patients. Therefore this study aimed to evaluate the relationships among visual loss and developmental level, and upper extremity functions, daily living activities and quality of life.

SUBJECTS AND METHODS

The study group consisted of children with spastic CP who were admitted to the Physical Medicine and Rehabilitation Clinic between November 2013 and February 2014. The children included in the study were aged 4–15 years and were diagnosed with diplegic CP according to the Swedish Classification11). Patients with genetic or metabolic disease and those with a progressive neurological disease were excluded from the study. Approval for the study was granted by the Institutional Ethics Committee of Harran University, and written informed consent was obtained from all the parents of the patients. For the determination of the developmental levels and mental capabilities of the children with CP, the Ankara Developmental Screening Inventory (ADSI), which has been tested for validity and reliability in Turkey, was used12,13,14). The ADSI is a scale which can be used to assess children aged 0–6 years to evaluate their communication-cognitive (CC), fine motor (FM), gross motor (GM), social skills-self care (SS-SC) and general development (GD) domains. The inventory consists of 154 items which are answered by the mothers, and responses are given as ‘yes’, ‘no’, or ‘don’t know’. The total score of the test reflects a subject’s general developmental level. Those with an average two standard deviations below the norm are evaluated as developmentally retarded12). Children over 6 years of age were evaluated with the mental development WISC-R test. For children who could not be evaluated by the age-appropriate test as they were developmentally aged below 6 years, even though their chronological age was over 6 years, the ADSI was conducted. The ophthalmological examinations of all the patients were conducted by the same ophthalmologist. Refraction errors, fundus examination, slit-lamp biomicroscopic examination, intraocular pressure measurement and oculomotor examinations were conducted. Compliance with the tests could not be achieved by any patient in assessment of visual acuity. The GMFCS is a classification system which has been developed for children with CP. It is separated into 5 levels based on gross motor functions such as starting movements by oneself, sitting and walking. At Level I, in mobility within the community, disability is minimal or absent. At Level V, mobility is totally dependent, even with the use of assistive aids15). Hand functions of children with CP while they are holding objects in daily living activities were evaluated using the MACS scale. The aim is to define the hand performance. The MACS scale has 5 levels. At Level I, the patient can easily and successfully hold the objects. At Level V, an object cannot be held by the subject who has severely limited capability for any activity16). The BFMF was developed to evaluate the hand functions separately. It has 5 levels. At Level I, one hand can be used without any restriction and there is restriction in the fine motor skills of the other hand. At Level V, each hand can only hold at best17). The Functional Independence Measure of children (WeeFIM) consists of 6 sub-categories. There are a total of 18 items: 6 items of self-care, 2 items of sphincter control, 3 items of transfer, 2 items of locomotion, 2 items of communication and 3 items of social cognition. Each item is scored from 1 to 7, with 1 indicating full help and 7 indicating full independence. The total score can range from a minimum of 18 to a maximum of 12618). The Paediatric Quality of Life Scale (PedsQL) is a quality of life scale developed by Varni et al. to measure the quality of life of chidren and adolescents aged 2–18 years19). The areas of physical health, emotional functionality and social functionality are surveyed as the characteristics of health status defined by the World Health Organisation. Functionality at school is also surveyed. Scores are calculated for three domains. First, the total points (MTP), then the physical health total (PHTP), and finally the psychosocial health (PSHTP) are calculated from the item scores evaluating emotional, social and school functionality20). The PedsQL is a quality of life scale consisting of 23 items which is suitable for use for the general population, such as in schools or hospitals, for both healthy and sick children and adolescents. The items are scored between 0–100. A response of never scores 100, rarely 75, sometimes 50, often 25 and always, 0. The higher the total score in the PedsQL, the better the quality of life is perceived in relation to health20). Important properties of the PedsQL are that it is short and can be completed in 5–10 minutes, it can be conducted by a researcher and the scoring is easy20, 21). In the current study, the PedsQL children and parent forms were used. Previous studies have been demonsrated on the validity and reliability of the Turkish version of PedsQL for the 2–18 years age group22,23,24). Statistical analyses were carried out using SPSS 18.0 for Windows (PASW Statistics for Windows, SPSS Inc., Chicago, Illinois, USA). Spearman correlation coefficients were used to determine the relationships between variables. All demographic and quantitative data are expressed as mean ± standard deviation (SD). Differences with p values < 0.05 were considered statistically significant and all results are expressed with a 95% confidence interval. The overall agreement between each GMFCS, MACS and BFMF values were analyzed using non-weighted Kappa statistics. Kappa values of <0.20 show poor agreement, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good, and >0.80 very good agreement25, 26).

RESULTS

The study included 32 patients, 16 males and 16 females with a mean age of 90.50±31.60 months (range, 50–172 months). Five (15.6%) of the patients were pre-term and 27 (84.4%) were term. Six (18.8%) of the patients had a low birth-weight, 10 (32.3%) had epilepsy and 14 (43.8%) had a history of anoxia. Twenty-two (68.8%) patients were delivered by the normal vaginal route, and 10 (31.3%) by caesarian section. The mean time of CP diagnosis was 12.96±9.41 months and the mean time to starting rehabilitation was 21.93±19.16 months. WeeFIM, PedsQL scores, developmental evaluation, and the distribution of patients according to GMFCS, BFMF and MACS are shown in Table 1.
Table 1.

Clinical characteristics of the patients

Characteristic Total, n=32n (%)
Developmental evaluation
Normal14 (43.8)
Retarded 18 (56.3)
WeeFIM total score, mean (SD)77.87±45.05
Child form of PedsQL, mean (SD)
PedsQL total score 40.25±33.96
PedsQL physical score40.40±33.25
PedsQL psychosocial score 40.41±35.39
Parent form of PedsQL, mean (SD)
PedsQL total score43.44±31.51
PedsQL physical score38.83±33.48
PedsQL psychosocial score45.22±31.89
GMFCS, levels
116 (50)
25 (15.6)
31 (3.1)
49 (28.1)
51 (3.1)
MACS, levels
110 (31.3)
218 (56.3)
32 (6.3)
41 (3.1)
51 (3.1)
BFMF, levels
118 (56.3)
28 (25)
33 (9.4)
42 (6.3)
51 (3.1)

BFMF: Bimanual Fine Motor Function, GMFCS: Gross Motor Function Classification System, MACS: Manual Ability Classification System, PedsQL: Paediatric Quality of Life Scale, WeeFIM: The Functional Independence Measure of children

BFMF: Bimanual Fine Motor Function, GMFCS: Gross Motor Function Classification System, MACS: Manual Ability Classification System, PedsQL: Paediatric Quality of Life Scale, WeeFIM: The Functional Independence Measure of children Developmental evaluation of 25 (78.1%) patients was made using the ADSI. Of these 12 (48%) were aged below 6 years and 13 (52%) could not perform the age-appropriate test even though they were aged over 6 years. The distribution of the patients according to the ADSI test is shown in Table 2. Of the 7 (21.9%) patients assessed using the WISC-R, 3 were evaluated as retarded general development and 4 as normal development.
Table 2.

Distribution of the patients according to the ADSI test

Total, n=25 ADSI-GDADSI-CCADSI-FMADSI-GMADSI-SC
Normal, n (%)10 (40)12 (48)9 (36)5 (20)12 (48)
Retarded, n (%)15 (60)13 (52)16 (64)20 (80)13 (52)

ADSI: Ankara Developmental Screening Inventory, GD: general development, CC: communication-cognitive, FM: fine motor, GM: gross motor, SC: social skills-self-care

ADSI: Ankara Developmental Screening Inventory, GD: general development, CC: communication-cognitive, FM: fine motor, GM: gross motor, SC: social skills-self-care In the ophthalmology examination, biomicroscopy of 31 (96.9%) patients was normal. In 1 (3.1%) patient, bilateral aphakia and micro cornea were determined. Bilateral mixed type astigmatism was determined in 2 (6.3%) patients and glaucomatous optic atrophy in 2 (6.3%) patients. The findings of the ophthalmology examinations are shown in Table 3.
Table 3.

Findings of the ophthalmology examinations

Ophthalmological findingsTotal, n=32n (%)
Biomicroscopic examination
Normal31 (96.9)
Bilateral aphakia1 (3.1)
Fundus examination
Normal25 (78.1)
Unilateral optic atrophy2 (6.3)
Bilateral optic atrophy 3 (9.4)
Glaucomatous optic atrophy2 (6.3)
Strabismus
Exotropia4 (12.5)
Esotropia 1 (3.1)
Refraction errors
Normal30 (93.8)
Mixed type astigmatism2 (6.3)
Right eye intraocular pressure, mean±SD (range), mmHg15.65±3.37 (11–30)
Left eye intraocular pressure, mean±SD (range), mmHg15.81±3.45 (11–31)
A significant positive correlation was determined between the GMFCS and BFMF scores (r=0.636, p<0.001). The Kappa value was calculated and the overall agreement between the GMFCS and BFMF was fair (Kappa value=0.288) (Table 4).
Table 4.

Distribution of GMFCS and BFMF levels

GMFCS LevelsBFMF levels

12345Total
113 (40.6)3 (9.4)---16 (50)
23 (9.4)2 (6.3)---5 (15.6)
3--1 (3.1) --1 (3.1)
42 (6.3)3 (9.4)2 (6.3)1 (3.1)1 (3.1)9 (28.1)
5---1 (3.1)-1 (3.1)
Total18 (56.3)8 (25)3 (9.4)2 (6.3)1 (3.1)32 (100)

Kappa: 0.288 p=0.004. BFMF: Bimanual Fine Motor Function, GMFCS: Gross Motor Function Classification System

Kappa: 0.288 p=0.004. BFMF: Bimanual Fine Motor Function, GMFCS: Gross Motor Function Classification System A significant positive correlation was determined between the GMFCS and MACS scores (r=0.553, p=0.001). The Kappa value was calculated and the overall agreement between the GMFCS and MACS was fair (Kappa value=0.202) (Table 5).
Table 5.

Distribution of GMFCS and MACS levels

GMFCS LevelsMACS levels

12345Total
18 (25)8 (25)---16 (50)
22 (6.3)3 (9.4)---5 (15.6)
3--1 (3.1)--1 (3.1)
4-6 (18.8)1 (3.1)1 (3.1)1 (3.1)9 (28.1)
5-1 (3.1)---1 (3.1)
Total10 (31.3)18 (56.3)2 (6.3)1 (3.1)1 (3.1)32 (100)

Kappa=0.202 p=0.018. GMFCS: Gross Motor Function Classification System, MACS: Manual Ability Classification System

Kappa=0.202 p=0.018. GMFCS: Gross Motor Function Classification System, MACS: Manual Ability Classification System A significant positive correlation was determined between the MACS and BFMF scores (r=0.718, p<0.001). The Kappa value was calculated and the overall agreement between the MACS and BFMF was moderate (Kappa value=0.537) (Table 6).
Table 6.

Distribution of BFMF and MACS levels

BFMF levelsMACS levels

12345Total
110 (31.3)8 (25)---18 (56.3)
2-8 (25)---8 (25)
3-1 (3.1)2 (6.3)--3 (9.4)
4-1 (3.1)-1 (3.1)-2 (6.3)
5----1 (3.1)1 (3.1)
Total10 (31.3)18 (56.3)2 (6.3)1 (3.1)1 (3.1)32 (100)

Kappa= 0.537 p<0.001. BFMF: Bimanual Fine Motor Function, MACS: Manual Ability Classification System

Kappa= 0.537 p<0.001. BFMF: Bimanual Fine Motor Function, MACS: Manual Ability Classification System The relationships between ocular and oculomotor disorders, GMFCS, BFMF and MACS and daily life activities and quality of life are shown in Table 7. The relationships between general development, ADSI evaluation, ocular and oculomotor disorders, GMFCS, BFMF and MACS and daily living activities and quality of life are shown in Table 8.
Table 7.

Correlation among oculomotor disorders, GMFCS, BFMF and MACS, WeeFIM and quality of life

Total cases (n=32)WeeFIMPedsQL-MTP-CFPedsQL-PHTP-CFPedsQL-PSHTP-CFPedsQL-MTP-PFPedsQL-PHTP-PFPedsQL-PSHTP-
GMFCS−0.802**−0.788**−0.836**−0.789**−0.788**−0.844**−0.710**
BFMF−0.769**−0.693**−0.661**−0.685**−0.729**−0.712**−0.668**
MACS−0.765**−0.806**−0.715**−0.803**−0.864**−0.765**−0.859**
Fundus pathology−0.128−0.008−0.079−0.050−0.139−0.109−0.156
Strabismus−0.220−0.297−0.312−0.284−0.191−0.300−0.168

**Correlation is significant at the 0.01 level (two-tailed). BFMF: Bimanual Fine Motor Function, CF: Child form, MACS: Manual Ability Classification System, GMFCS: Gross Motor Function Classification System, MTP: measured total points, PF: Parent form, PedsQL: Paediatric Quality of Life Scale, PHTP: physical health total points, PSHTP: psychosocial health total points

Table 8.

Correlation of the developmental level with oculomotor disorders, GMFCS, BFMF, MACS, WeeFIM and quality of life scores

ADSI-GDn=25ADSI-CCn=25ADSI-FMn=25ADSI-GMn=25ADSI-SCn=25Generaldevelopmentn=32
GMFCS0.612**0.756**0.556**0.2620.756**0.518**
BFMF0.675**0.590**0.726**0.2010.590**0.646**
MACS0.490*0.468*0.507**0.3000.468*0.537**
WeeFIM−0.700**−0.720**−0.691**−0.279−0.764**−0.645**
PedsQL- MTP-CF−0.645**−0.791**−0.552**−0.296−0.762**−0.669**
PedsQL- PHTP -CF−0.597**−0.768**−0.503**−0.213−0.711**−0.631**
PedsQL- PSHTP -CF−0.632**−0.802**−0.562**−0.241−0.768**−0.679**
PedsQL- MTP-PF−0.691**−0.789**−0.659**−0.264−0.756**−0.710**
PedsQL- PHTP -PF−0.743**−0.838**−0.657**−0.215−0.786**−0.754**
PedsQL- PSHTP -PF−0.573**−0.695**−0.642**−0.236−0.651**−0.629**
Fundus pathology0.1340.2010.327−0.0550.2010.010
Strabismus0.0000.080−0.0420.0000.0800.033

**Correlation is significant at the 0.01 level (two-tailed). ADSI: Ankara Developmental Screening Inventory, BFMF: Bimanual Fine Motor Function, CC: communication-cognitive, CF: Child form, FM: fine motor, GD: general development, GM: gross motor, GMFCS: Gross Motor Function Classification System, MACS: Manual Ability Classification System, MTP: measured total points, PF: Parent form, PedsQL: Paediatric Quality of Life Scale, PHTP: physical health total points, PSHTP: psychosocial health total points, SC: social skills-self-care

**Correlation is significant at the 0.01 level (two-tailed). BFMF: Bimanual Fine Motor Function, CF: Child form, MACS: Manual Ability Classification System, GMFCS: Gross Motor Function Classification System, MTP: measured total points, PF: Parent form, PedsQL: Paediatric Quality of Life Scale, PHTP: physical health total points, PSHTP: psychosocial health total points **Correlation is significant at the 0.01 level (two-tailed). ADSI: Ankara Developmental Screening Inventory, BFMF: Bimanual Fine Motor Function, CC: communication-cognitive, CF: Child form, FM: fine motor, GD: general development, GM: gross motor, GMFCS: Gross Motor Function Classification System, MACS: Manual Ability Classification System, MTP: measured total points, PF: Parent form, PedsQL: Paediatric Quality of Life Scale, PHTP: physical health total points, PSHTP: psychosocial health total points, SC: social skills-self-care

DISCUSSION

This study found a significant relationship between developmental retardation in CP patients and disease severity, hand functions, daily living activities and quality of life. We also determined that MACS and BFMF conform with each other and with the severity of CP, and that as CP severity increases, hand skills worsen. It has been reported that BFMF is used more to define disability and MACS to evaluate activity although it is stated that it is difficult to compare these two scales26). Another study reported a strong positive correlation between BFMF and MACS with good overall agreement10). In the present study, a strong positive correlation was determined between BFMF and MACS. The overall agreement between MACS and BFMF was moderate. In addition, a strong correlation was found between GMFCS and BFMF, and GMFCS and MACS. The overall agreement was fair, a result that is consistent with previous studies10, 26, 27). Although the corrrelations between the scales were high, the reason for low overall agreement, which was calculated using the Kappa statistic, is that the Kappa statistic is a method which is actually used in the evaluation of the same scale by two different researchers. For the evaluation of the agreement of two different scales, using the correlation coefficient is more appropriate25). There is a lower rate of upper extremity involvement in children with CP, so the low agreement found by the present study could be due to the evaluation of only diplegic CP children. In the present study, a significant relationship was shown between all the subscales of the WeeFIM and PedsQL scales with each of the GMFCS, MACS and BFMF scales. In a study which evaluated the relationships between WeeFIM and GMFCS and MACS in spastic CP patients, significant correlations were determined between the latter two scales and WeeFIM, similar to the results of our present27). As an explanation for these results, we consider that as CP severity increases, hand functions are impaired with deteriorations in daily living activities and quality of life. The visual process is a complex cerebral activity which involves a large part of the central nervous system28). It can be considered, therefore that visual deficits are often seen in the neurodevelopmental disabilities which are observed in CP. In CP patients with hypoxic ischaemia encephalopathy, not only the motor pathways, but also the visual pathways are affected29). Fundus pathologies associated with the trans-synaptic degeneration mechanism may develop in such patients30). In support of this view, a MRI study of CP children with visual problems showed trans-synaptic degeneration of the lateral geniculate body31). Studies have also shown there is a relationship between the severity of visual sensory problems in children with CP and mental motor deficits6, 8, 32). Therefore, early referral of CP children to an ophthalmologist can be an important factor in increasing mental and motor capacity. In the present study, fundus pathology was determined in 21.9%, strabismus in 15.6% and refractive error in 6.3% of patients. However, no significant correlations were determined between the functional status, quality of life and developmental level of CP patients with fundus pathology or strabismus. Cerebral visual impairment is defined as the involvement of the retrogeniculate pathways in symptoms such as reduced visual field and visual acuity. It has been determined in 60–70% of children with CP33). In the present study, cerebral visual impairment in children with CP was not evaluated. Therefore, a significant corrrelation may not have been revealed between oculomotor dysfunction and functional status, quality of life and developmental level in children without oculomotor dysfunction who may have visual problems. In the present study, significant correlations were determined between general developmental level and the functional status and quality of life of the children. In children evaluated with the ADSI, significant relationships were also determined between functional status and quality of life and all the subscales of ADSI except the ADSI-GM subscale. The motivation of the children and general developmental levels may affect hand skills. Therefore, when there is a poor functional status in children with good general development and high capacity expectations, motivational factors can be considered to be exerting an effect and different treatment strategies should be defined. Limitations of the present study were the inclusion of only diplegic type spastic CP patients, and the lack of evaluation of cerebral visual impairment, visuocognitive dysfunction or visuoperceptual diseases in the ophthalmology examination. In conclusion, GMFCS, MACS and BFMF can be useful in the determination of the functional status of children with CP as they are easy, practical and simple classification scales which are consistent with each other. Ophthalmological examination of children with CP in the early period and early treatment strategies may enhance the possibility of increasing the mental and motor development of these children. However, there is a need for further larger studies with detailed neuro-ophthalmological evaluation including CP patients with different clinical characteristics.
  26 in total

1.  Visual problems as a result of brain damage in children.

Authors:  G N Dutton; E C A McKillop; S Saidkasimova
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

2.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

3.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

Review 4.  Cerebral visual impairment in children.

Authors:  G N Dutton; L K Jacobson
Journal:  Semin Neonatol       Date:  2001-12

5.  Visual function and visual perception in cerebral palsied children.

Authors:  Nikos Kozeis; Antonia Anogeianaki; Daniela Tosheva Mitova; George Anogianakis; Tosho Mitov; Anelia Klisarova
Journal:  Ophthalmic Physiol Opt       Date:  2007-01       Impact factor: 3.117

6.  Transsynaptic degeneration of lateral geniculate bodies in blind children: in vivo MR demonstration.

Authors:  C Uggetti; M G Egitto; E Fazzi; P E Bianchi; F Zappoli; A Martelli; G Lanzi
Journal:  AJNR Am J Neuroradiol       Date:  1997-02       Impact factor: 3.825

7.  Visual disorders associated with cerebral palsy.

Authors:  P Black
Journal:  Br J Ophthalmol       Date:  1982-01       Impact factor: 4.638

8.  Frequency and severity of visual sensory and motor deficits in children with cerebral palsy: gross motor function classification scale.

Authors:  Fatema Ghasia; Janice Brunstrom; Mae Gordon; Lawrence Tychsen
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

9.  Relationships between Physical and Cognitive Functioning and Activities of Daily Living in Children with Cerebral Palsy.

Authors:  Chiang-Soon Song
Journal:  J Phys Ther Sci       Date:  2013-06-29

10.  Association between gross motor function (GMFCS) and manual ability (MACS) in children with cerebral palsy. A population-based study of 359 children.

Authors:  Katharina Delhusen Carnahan; Marianne Arner; Gunnar Hägglund
Journal:  BMC Musculoskelet Disord       Date:  2007-06-21       Impact factor: 2.362

View more
  2 in total

1.  Visual Function and Neuropsychological Profile in Children with Cerebral Visual Impairment.

Authors:  Federica Morelli; Giorgia Aprile; Chiara Martolini; Elena Ballante; Lucrezia Olivier; Elisa Ercolino; Eleonora Perotto; Sabrina Signorini
Journal:  Children (Basel)       Date:  2022-06-19

2.  Ocular findings in patients with spastic type cerebral palsy.

Authors:  Myung Jin Park; Yung Ju Yoo; Chin Youb Chung; Jeong-Min Hwang
Journal:  BMC Ophthalmol       Date:  2016-11-08       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.